DAEWON Chemical Co., Ltd.

KRX:024890.KS

1163 (KRW) • At close October 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 122,178.458146,805.184113,339.078108,787.317133,052.794114,627.062118,378.91124,361.109144,638.525131,565.869108,178.448120,545.969120,190.563107,040.051118,011.09793,019.61681,765.267
Cost of Revenue 109,113.273130,041.62799,705.93191,400.69106,595.56594,465.37791,423.38795,566.304111,230.788104,731.34890,872.645106,486.157108,004.02796,583.974106,616.16984,309.96369,728.332
Gross Profit 13,065.18416,763.55713,633.14717,386.62726,457.2320,161.68526,955.52328,794.80533,407.73626,834.52117,305.80314,059.81212,186.53510,456.07711,394.9288,709.65312,036.935
Gross Profit Ratio 0.1070.1140.120.160.1990.1760.2280.2320.2310.2040.160.1170.1010.0980.0970.0940.147
Reseach & Development Expenses 1,690.6841,664.7511,474.3821,707.5871,524.4171,766.6491,938.9642,583.5062,148.8572,064.4012,503.9472,577.1751,634.6362,435.6672,253.1612,154.5341,752.322
General & Administrative Expenses 1,909.9291,678.5921,371.1191,570.7442,137.7021,735.2261,662.561,825.3561,864.1061,688.711,579.1631,891.8931,895.8771,599.6812,293.7392,628.4411,816.336
Selling & Marketing Expenses 6,258.3918,324.5435,923.365,062.0486,847.7463,989.7544,167.3554,271.0854,976.8473,599.1693,210.8013,840.9935,754.4844,481.7384,089.9444,001.9982,873.131
SG&A 17,039.45810,003.1357,294.4796,632.7928,985.4485,724.985,829.9156,096.4416,840.9535,287.8794,789.9645,732.8867,650.3616,081.4196,383.6836,630.4394,689.467
Other Expenses -909.88512,496.70613,295.548,698.0267,679.755-707.249-4,152.837-1,966.637-4,085-3,204.688-1,657.178-274.694142-2,915.22-553.129-1,025.349-196.32
Operating Expenses 19,640.02724,164.59222,064.40117,038.40518,189.6216,549.19916,934.66716,357.26714,977.28912,770.84412,081.74513,147.12115,211.53313,796.16913,434.25313,356.8419,893.278
Operating Income -6,574.842-7,401.035-8,431.254348.2218,267.6093,612.48410,020.85512,437.5418,430.44814,063.6785,224.058912.69-3,797.398-3,340.095-2,039.325-4,647.1882,143.656
Operating Income Ratio -0.054-0.05-0.0740.0030.0620.0320.0850.10.1270.1070.0480.008-0.032-0.031-0.017-0.050.026
Total Other Income Expenses Net -2,606.338-1,581.411-129.896-2,048.204-1,513.548-1,756.325-5,844.172-3,079.405-5,412.052-6,783.069-6,010.162-6,053.44-3,695.773-6,850.539-825.283-5,126.087-719.131
Income Before Tax -9,181.18-8,982.446-8,561.15-1,699.9836,754.0611,856.1614,176.6839,358.13313,018.3967,280.608-786.104-5,140.749-6,720.771-10,190.631-2,864.608-9,773.2751,424.526
Income Before Tax Ratio -0.075-0.061-0.076-0.0160.0510.0160.0350.0750.090.055-0.007-0.043-0.056-0.095-0.024-0.1050.017
Income Tax Expense 563.671639.398-1,557.502483.167894.002773.5522,590.8712,131.0161,538.111,455.112524.949-159.761-310.267-2,475.334161.956-1,954.85989.813
Net Income -9,745.133-9,621.845-7,003.648-2,183.155,866.7881,083.4311,585.8127,227.11711,480.2865,825.496-1,311.053-4,980.989-6,410.504-7,715.297-3,026.564-7,818.4161,334.713
Net Income Ratio -0.08-0.066-0.062-0.020.0440.0090.0130.0580.0790.044-0.012-0.041-0.053-0.072-0.026-0.0840.016
EPS -239.09-236.06-171.75-53.18142.6926.3539176301182-44-169-216.86-273-116-30051.5
EPS Diluted -239.09-236.06-171.75-53.18142.692639176301157-44-169-216.86-273-116-26048.3
EBITDA -4,031.191-5,004.275-5,794.352,533.11811,824.1125,254.717,784.48813,417.9418,164.81413,453.366,270.6672,239.798-1,868.722-3,097.3021,312.169-5,487.0234,965.248
EBITDA Ratio -0.033-0.034-0.0510.0230.0890.0460.0660.1080.1260.1020.0580.019-0.016-0.0290.011-0.0590.061